Intesi Group and Adobe address the challenges of electronic informed consent

What the future looks like is difficult to predict, but health care services should reach people in need even remotely.

 

In the context of speeding up the digital adoption in pharma and health care, one fundamental aspect is related to the patient informed consent for therapies and accessing their sensitive data.

 

Intesi Group and Adobe joined their forces in bringing a service that will eliminate waiting times for patients with serious conditions, allowing physicians to dedicate their efforts to the medical act.

 

Have a look at how Adobe Sign and Intesi Group address the challenges of electronic informed consent, helping Life Sciences to stay compliant with EU Clinical Trials Regulation, GDPR and FDA Guidance for IRBs, Clinical Investigators and Sponsors.

 

For further information: lifescience@intesigroup.com

 

Download the story

 

 

 

 

Back to News